過去の関連発表

McEwan P, Ward T, Yuan Y, Kalsekar A, Kamae I, Kobayashi M, Inoue S, Tang A, Kumada H. Estimating projected costs and quality-adjusted life expectancy associated with Daclatasvir plus Asunaprevir in difficult to treat Japanese patients chronically infected with HCV Genotype 1b. The annual AASLD liver meeting, 7-11 November, 2014, Boston, MA, USA.

  • McEwan P, Ward T, Yuan Y, Kalsekar A, Kamae I, Kobayashi M, Inoue S, Tang A, Kumada H. Estimating projected costs and quality-adjusted life expectancy associated with Daclatasvir plus Asunaprevir in difficult to treat Japanese patients chronically infected with HCV Genotype 1b. The annual AASLD liver meeting, 7-11 November, 2014, Boston, MA, USA.